This company has been marked as potentially delisted and may not be actively trading. Lianluo Smart (LLIT) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrendsBuy This Stock LLIT vs. APYX, MDAI, TMDIF, FEMY, DRIO, HSAQ, NMTC, PYPD, RVP, and NEPHShould you be buying Lianluo Smart stock or one of its competitors? The main competitors of Lianluo Smart include Apyx Medical (APYX), Spectral AI (MDAI), Titan Medical (TMDIF), Femasys (FEMY), DarioHealth (DRIO), Health Sciences Acquisitions Co. 2 (HSAQ), NeuroOne Medical Technologies (NMTC), PolyPid (PYPD), Retractable Technologies (RVP), and Nephros (NEPH). These companies are all part of the "medical" sector. Lianluo Smart vs. Apyx Medical Spectral AI Titan Medical Femasys DarioHealth Health Sciences Acquisitions Co. 2 NeuroOne Medical Technologies PolyPid Retractable Technologies Nephros Apyx Medical (NASDAQ:APYX) and Lianluo Smart (NASDAQ:LLIT) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, community ranking, media sentiment, risk and dividends. Is APYX or LLIT more profitable? Lianluo Smart has a net margin of 0.00% compared to Apyx Medical's net margin of -58.59%. Lianluo Smart's return on equity of 0.00% beat Apyx Medical's return on equity.Company Net Margins Return on Equity Return on Assets Apyx Medical-58.59% -137.98% -36.74% Lianluo Smart N/A N/A N/A Do analysts rate APYX or LLIT? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Apyx Medical 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.67Lianluo Smart 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media prefer APYX or LLIT? In the previous week, Apyx Medical had 5 more articles in the media than Lianluo Smart. MarketBeat recorded 5 mentions for Apyx Medical and 0 mentions for Lianluo Smart. Apyx Medical's average media sentiment score of 0.37 beat Lianluo Smart's score of 0.00 indicating that Apyx Medical is being referred to more favorably in the media. Company Overall Sentiment Apyx Medical Neutral Lianluo Smart Neutral Which has stronger valuation & earnings, APYX or LLIT? Lianluo Smart has lower revenue, but higher earnings than Apyx Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioApyx Medical$48.10M0.98-$18.71M-$0.67-1.87Lianluo Smart$380K20.95-$4.45MN/AN/A Does the MarketBeat Community believe in APYX or LLIT? Lianluo Smart received 26 more outperform votes than Apyx Medical when rated by MarketBeat users. Likewise, 70.27% of users gave Lianluo Smart an outperform vote while only 60.94% of users gave Apyx Medical an outperform vote. CompanyUnderperformOutperformApyx MedicalOutperform Votes7860.94% Underperform Votes5039.06% Lianluo SmartOutperform Votes10470.27% Underperform Votes4429.73% Which has more volatility & risk, APYX or LLIT? Apyx Medical has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500. Comparatively, Lianluo Smart has a beta of 0.16, indicating that its stock price is 84% less volatile than the S&P 500. Do institutionals and insiders believe in APYX or LLIT? 55.3% of Apyx Medical shares are owned by institutional investors. Comparatively, 28.8% of Lianluo Smart shares are owned by institutional investors. 16.8% of Apyx Medical shares are owned by company insiders. Comparatively, 22.9% of Lianluo Smart shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryLianluo Smart beats Apyx Medical on 8 of the 15 factors compared between the two stocks. Get Lianluo Smart News Delivered to You Automatically Sign up to receive the latest news and ratings for LLIT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LLIT vs. The Competition Export to ExcelMetricLianluo SmartSurgical & Medical Instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.96M$4.39B$5.55B$8.04BDividend YieldN/A39.93%5.09%4.22%P/E RatioN/A29.8622.6818.83Price / Sales20.9557.90404.28106.72Price / CashN/A51.0838.1834.62Price / Book-6.106.226.794.33Net Income-$4.45M$68.15M$3.22B$247.97M Lianluo Smart Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LLITLianluo SmartN/A$3.60-2.7%N/A+356.8%$7.96M$380,000.000.006APYXApyx Medical1.3893 of 5 stars$0.90-0.4%N/A-23.6%$33.71M$48.10M-1.07270Upcoming EarningsShort Interest ↑News CoverageMDAISpectral AI2.9983 of 5 stars$1.30-0.4%$4.75+266.8%-25.0%$32.79M$29.58M-1.9983Upcoming EarningsShort Interest ↓Positive NewsTMDIFTitan MedicalN/A$0.29+7.9%N/A+529.6%$32.79M$17.63M-0.2350FEMYFemasys3.3025 of 5 stars$1.19+2.6%$11.50+866.4%-10.0%$32.31M$1.63M-1.4730Upcoming EarningsShort Interest ↓Positive NewsDRIODarioHealth2.4164 of 5 stars$0.72-8.2%$1.50+107.8%-50.5%$30.01M$27.04M-0.77200News CoverageGap UpHSAQHealth Sciences Acquisitions Co. 2N/A$2.61-6.1%N/A-32.5%$29.26MN/A0.004Gap UpNMTCNeuroOne Medical Technologies0.5117 of 5 stars$0.61-2.9%N/A-46.7%$28.76M$5.75M-2.3320PYPDPolyPid2.1498 of 5 stars$2.64+4.7%$11.33+329.5%-44.0%$26.89MN/A-0.5380Upcoming EarningsShort Interest ↑Gap DownHigh Trading VolumeRVPRetractable TechnologiesN/A$0.74+2.3%N/A-31.9%$22.22M$33.05M-1.37240NEPHNephros2.5658 of 5 stars$1.95-2.5%$5.00+156.4%-19.0%$20.67M$14.16M-21.6730Upcoming EarningsShort Interest ↓Gap Down Related Companies and Tools Related Companies Apyx Medical Competitors Spectral AI Competitors Titan Medical Competitors Femasys Competitors DarioHealth Competitors Health Sciences Acquisitions Co. 2 Competitors NeuroOne Medical Technologies Competitors PolyPid Competitors Retractable Technologies Competitors Nephros Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LLIT) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lianluo Smart Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Lianluo Smart With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LLIT Stock Free LLIT Stock Alerts